Suppr超能文献

充血性心力衰竭发展过程中基质金属蛋白酶抑制作用:对左心室大小和功能的影响

Matrix metalloproteinase inhibition during the development of congestive heart failure : effects on left ventricular dimensions and function.

作者信息

Spinale F G, Coker M L, Krombach S R, Mukherjee R, Hallak H, Houck W V, Clair M J, Kribbs S B, Johnson L L, Peterson J T, Zile M R

机构信息

Division of Cardiothoracic Surgery, Medical University of South Carolina, Charleston 29425, USA.

出版信息

Circ Res. 1999 Aug 20;85(4):364-76. doi: 10.1161/01.res.85.4.364.

Abstract

The development of congestive heart failure (CHF) is associated with left ventricle (LV) dilation and myocardial remodeling. The matrix metalloproteinases (MMPs) play a significant role in extracellular remodeling, and recent studies have demonstrated increased MMP expression and activity with CHF. Whether increased MMP activity directly contributes to the LV remodeling with CHF remains unknown. Accordingly, this study examined the effects of chronic MMP inhibition (MMPi) on LV size and function during the progression of CHF. Pigs were assigned to the following groups: (1) CHF, rapid pacing for 3 weeks at 240 bpm (n=12); (2) CHF/MMPi, rapid pacing and concomitant MMPi (PD166793, 20 mg/kg per day [n=10]), and (3) control (n=11). With pacing CHF, LV fractional shortening was reduced (19+/-1 versus 45+/-1%), and end-diastolic dimension increased (5.67+/-0.11 versus 3.55+/-0.05 cm), compared with baseline values (P<0.05). In the CHF/MMPi group, LV endocardial shortening increased (25+/-2%) and the end-diastolic dimension was reduced (4.92+/-0.17 cm) compared with CHF-only values (P<0.05). LV midwall shortening was reduced to a comparable degree in the CHF-only and CHF/MMPi groups. LV peak wall stress increased 3-fold with pacing CHF compared with controls and was significantly reduced in the CHF/MMPi group. LV myocardial stiffness was unchanged with CHF but was increased in the CHF/MMPi group. LV myocyte length was increased with pacing CHF compared with controls (180+/-3 versus 125+/-4 microm, P<0.05) and was reduced in the CHF/MMPi group (169+/-4 microm, P<0.05). Basal-state myocyte shortening velocity was reduced with pacing CHF compared with controls (33+/-2 versus 66+/-1 microm/s, P<0.05) and was unchanged in the CHF/MMPi group (31+/-2 microm/s). Using an ex vivo assay system, myocardial MMP activity was increased with pacing CHF and was reduced with chronic MMPi. In summary, concomitant MMPi with developing CHF limited LV dilation and reduced wall stress. These results suggest that increased myocardial MMP activity contributes to LV myocardial remodeling in developing CHF.

摘要

充血性心力衰竭(CHF)的发展与左心室(LV)扩张和心肌重塑有关。基质金属蛋白酶(MMPs)在细胞外重塑中起重要作用,最近的研究表明CHF时MMP表达和活性增加。MMP活性增加是否直接导致CHF时的LV重塑尚不清楚。因此,本研究探讨了慢性MMP抑制(MMPi)对CHF进展过程中LV大小和功能的影响。将猪分为以下几组:(1)CHF组,以240次/分钟的频率快速起搏3周(n = 12);(2)CHF/MMPi组,快速起搏并同时给予MMPi(PD166793,每天20mg/kg [n = 10]),以及(3)对照组(n = 11)。与基线值相比,起搏诱导CHF时,LV缩短分数降低(19±1%对45±1%),舒张末期内径增加(5.67±0.11cm对3.55±0.05cm)(P<0.05)。与仅CHF组相比,CHF/MMPi组LV心内膜缩短增加(25±2%),舒张末期内径减小(4.92±0.17cm)(P<0.05)。CHF组和CHF/MMPi组LV中层壁缩短程度降低程度相当。与对照组相比,起搏诱导CHF时LV峰值壁应力增加3倍,而CHF/MMPi组显著降低。CHF时LV心肌僵硬度未改变,但CHF/MMPi组增加。与对照组相比,起搏诱导CHF时LV心肌细胞长度增加(180±3μm对125±4μm,P<0.05),CHF/MMPi组降低(169±4μm,P<0.05)。与对照组相比,起搏诱导CHF时基础状态下心肌细胞缩短速度降低(33±2μm/s对66±1μm/s,P<0.05),CHF/MMPi组未改变(31±2μm/s)。使用离体分析系统,起搏诱导CHF时心肌MMP活性增加,慢性MMPi可降低。总之,CHF发展过程中同时给予MMPi可限制LV扩张并降低壁应力。这些结果表明,心肌MMP活性增加促成了CHF发展过程中的LV心肌重塑。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验